{
  "docId": "019de511-116c-769a-af30-00a56112ffbd",
  "docSlug": "6dbbbde9942752c16f9f4678dff28ed3",
  "documentTitle": "Nyxoah | IPO Presentation Deck | 34 slides",
  "authorId": "nyxoah",
  "authorName": "Nyxoah",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2021-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7794254,
  "pageNumber": 6,
  "pageCount": 34,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "market_sizing",
  "function": "size_opportunity",
  "density": "overcrowded",
  "nDataPoints": 7,
  "notes": "Uses a dual-funnel/process flow structure to contrast the total addressable market (prevalence) with the current penetration of the specific therapy (HGNS).",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de511-116c-769a-af30-00a56112ffbd/6",
  "deckHref": "/decks/019de511-116c-769a-af30-00a56112ffbd",
  "deckJsonHref": "/decks/019de511-116c-769a-af30-00a56112ffbd.json",
  "deckAnchorHref": "/decks/019de511-116c-769a-af30-00a56112ffbd#slide-6",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.15,
        "x": 0.29,
        "y": 0.7
      },
      "kind": "chart",
      "text": "Undiagnosed OSA 80%",
      "attrs": null,
      "subkind": "pie",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d6ec86bb-5204-44a3-9307-b9bdf52b1653",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.55,
        "x": 0.03,
        "y": 0.88
      },
      "kind": "disclaimer",
      "text": "1. Benjafield, Adam V et al. Estimation of the global prevalence... 2. Harvard Medical School... 3. Presents annual revenue growth for Inspire Medical...",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "67087d92-d227-481e-ab7b-cb65940110ee",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.4,
        "x": 0.06,
        "y": 0.25
      },
      "kind": "list",
      "text": "936 Million individuals (30-69 year) are estimated to suffer from OSA; 425M suffer from moderate to severe OSA; Only 20% OSA patients are diagnosed",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4b0a837f-d5c8-445f-a86f-3a0cb74bf02a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.4,
        "x": 0.57,
        "y": 0.25
      },
      "kind": "list",
      "text": "1 Million yearly eligible for HGNS; < 13,000 received HGNS as treatment; +62% CAGR HGNS revenue 2016–2020",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "639aa98b-c86d-43c4-b5dd-bb3f94250510",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.75,
        "x": 0.03,
        "y": 0.03
      },
      "kind": "title",
      "text": "OSA and HGN Stimulation Markets are Huge, Growing and Under-penetrated",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9ddd11cc-4912-42bf-8b06-74c1e36d4770",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.25,
        "x": 0.67,
        "y": 0.16
      },
      "kind": "title",
      "text": "HGN stimulation market potential",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7f539603-1f39-4b21-b54c-47bbc909371c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.25,
        "x": 0.06,
        "y": 0.16
      },
      "kind": "title",
      "text": "OSA prevalence – Worldwide data",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f634d068-5636-4488-8440-4778ff79da9b",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "market-sizing",
      "slug": null,
      "matchId": "75a2dc7d-e510-4a35-a713-466fc330bfcd",
      "evidence": "Quantifies total addressable market vs. current penetration",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 6,
      "from": 6,
      "beatId": "06acbc44-6b10-49ee-aac1-0484b74fd9c7",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Market Size",
      "beatSlug": "sequoia-pitch-market-size",
      "evidence": "Slide 6 presents the market sizing for OSA and HGN Stimulation",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}